Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Matthew Riddle, Anne Peters & Martha Funnell. (2016) Increasing Patient Acceptance and Adherence Toward Insulin. Postgraduate Medicine 128:sup1, pages 11-20.
Read now
Read now
Michael H. Shannon, Neil Wintfeld, Michael Liang & Lois Jovanovic. (2016) Pregnancy snapshot: a retrospective, observational case–control study to evaluate the potential effects of maternal diabetes treatment during pregnancy on macrosomia. Current Medical Research and Opinion 32:7, pages 1183-1192.
Read now
Read now
Elizabeth L Eby, Kate Van Brunt, Cynthia Brusko, Bradley Curtis & Maureen J Lage. (2015) Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes. Clinical Interventions in Aging 10, pages 991-1001.
Read now
Read now
Articles from other publishers (24)
Xiaosu Ma, Charles T. Benson, Randy Prescilla, Shuyu Zhang, Helle Linnebjerg, Elizabeth S. LaBell, Linda A. Morrow, Jeffrey A. Jackson, Alex Nguyen, Liza L. Ilag, Jennal L. Johnson & Derek Leishman. (2020) Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements. Journal of Diabetes Science and Technology 16:2, pages 401-407.
Crossref
Crossref
Anil Gupta. 2022. Understanding Insulin and Insulin Resistance. Understanding Insulin and Insulin Resistance
29
70
.
Umesh Dashora, Suhail Ahmed, Syed Shaiq, Erwin Castro, Shahid Ahmed Khan, Irene Bossman & Pariasamy Sathiskumar. (2021) A case series of Humulin R U‐500 in insulin resistant people with type 2 diabetes. Practical Diabetes 38:6, pages 16-22.
Crossref
Crossref
Jieling Chen, Sujana Borra, Ludi Fan, Ahong Huang, Dhiren Patel & Rattan Juneja. (2021) Treatment patterns and outcomes before and after human regular U-500 insulin initiation via KwikPen® among US veterans with type 2 diabetes mellitus. Journal of Diabetes and its Complications 35:10, pages 107995.
Crossref
Crossref
Irl B Hirsch, Rattan Juneja, John M Beals, Caryl J Antalis & Eugene E WrightJr.Jr.. (2020) The Evolution of Insulin and How it Informs Therapy and Treatment Choices. Endocrine Reviews 41:5, pages 733-755.
Crossref
Crossref
Jieling Chen, Christi Y. Kao, Xuanyao He, Ludi Fan, Jeffrey A. Jackson & Rattan Juneja. (2020) Treatment Patterns, Adherence, and Persistence Associated With Human Regular U-500 Insulin: A Real-World Evidence Study. Diabetes Spectrum 33:3, pages 264-272.
Crossref
Crossref
Jieling ChenRadhika NairMir SiadatyKatelyn BrownYunus MeahApril Dawn TaylorXuanyao HeLudi Fan. (2020) Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes Mellitus. Journal of Managed Care & Specialty Pharmacy 26:7, pages 839-847.
Crossref
Crossref
Lutz Heinemann, John M. Beals, James Malone, James Anderson, Jennie G. Jacobson, Vikram Sinha & Sheila M. Corrigan. (2019) Concentrated insulins: History and critical reappraisal. Journal of Diabetes 11:4, pages 292-300.
Crossref
Crossref
Olesya Y. Gurova, Valentin V. Fadeev & Ekaterina S. Maloletkina. (2019) Injectable therapy in type 2 diabetes mellitus: strategies to improve therapeutic adherence. Diabetes mellitus 21:6, pages 524-533.
Crossref
Crossref
Leslie C Robinson, Richard C E Anderson, Douglas L Brockmeyer, Michelle R Torok & Todd C Hankinson. (2018) Comparison of Fusion Rates Based on Graft Material Following Occipitocervical and Atlantoaxial Arthrodesis in Adults and Children. Operative Neurosurgery 15:5, pages 530-537.
Crossref
Crossref
Paula M. Bergen, Davida F. Kruger, April D. Taylor, Wael E. Eid, Arti Bhan & Jeffrey A. Jackson. (2017) Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach. The Diabetes Educator 43:3, pages 311-323.
Crossref
Crossref
Robert C. Hood. (2017) Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?. Diabetes Technology & Therapeutics 19:4, pages 203-205.
Crossref
Crossref
Susan Renda & Kathleen Becker. (2017) The use of U-500 insulin for patients with severe insulin resistance. The Nurse Practitioner 42:3, pages 12-16.
Crossref
Crossref
Samaneh Kabul, Robert C. Hood, Ran Duan, Amy M. DeLozier & Julie Settles. (2016) Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial. Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
Samuel StolpeMichel A. KroesNeil WebbTami Wisniewski. (2016) A Systematic Review of Insulin Adherence Measures in Patients with Diabetes. Journal of Managed Care & Specialty Pharmacy 22:11, pages 1224-1246.
Crossref
Crossref
Beth D. Mitchell, Xuanyao He, Ian M. Sturdy, Andrew P. Cagle & Julie A. Settles. (2016) Glucagon Prescription Patterns In Patients With Either Type 1 Or 2 Diabetes With Newly Prescribed Insulin. Endocrine Practice 22:2, pages 123-135.
Crossref
Crossref
Elizabeth L. Eby, Kate Van Brunt, Cynthia Brusko, Bradley Curtis & Maureen J. Lage. (2015) Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States. Clinical Therapeutics 37:10, pages 2297-2308.e1.
Crossref
Crossref
Rebecca Schechter & Sirimon Reutrakul. (2015) Management of Severe Insulin Resistance in Patients with Type 1 Diabetes. Current Diabetes Reports 15:10.
Crossref
Crossref
Robert C. Hood, Richard F. Arakaki, Carol Wysham, Ying G. Li, Julie A. Settles & Jeffrey A. Jackson. (2015) Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target Clinical Trial. Endocrine Practice 21:7, pages 782-794.
Crossref
Crossref
Linda Tran, Angela Zielinski, Arpi H. Roach, Jennifer A. Jende, Ann Marie Householder, Emily E. Cole, Shuruq A. Atway, Melinda Amornyard, Mallory L. Accursi, Suzanna W. Shieh & Erin E. Thompson. (2015) Pharmacologic Treatment of Type 2 Diabetes. Annals of Pharmacotherapy 49:6, pages 700-714.
Crossref
Crossref
Sheila Anne Doggrell & Vincent Chan. (2014) Adherence to insulin treatment in diabetes: can it be improved?糖尿病患者使用胰岛素治疗的依从性：它能够得到改善吗？. Journal of Diabetes 7:3, pages 315-321.
Crossref
Crossref
Elizabeth L Eby, Bradley H Curtis, Steven C Gelwicks, Robert C Hood, Iskandar Idris, Anne L Peters, Richard M Bergenstal & Jeffrey A Jackson. (2015) Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study. BMJ Open Diabetes Research & Care 3:1, pages e000074.
Crossref
Crossref
Elizabeth L. Eby, Anthony J. Zagar, Ping Wang, Bradley H. Curtis, Jin Xie, Diane C. Haldane, Iskandar Idris, Anne L. Peters, Robert C. Hood & Jeffrey A. Jackson. (2014) Healthcare Costs and Adherence Associated with Human Regular U-500 Versus High-Dose U-100 Insulin in Patients with Diabets. Endocrine Practice 20:7, pages 663-670.
Crossref
Crossref
Elaine K. CochranVirginia ValentineKaren H. SamaanIlene B. CoreyJeffrey A. Jackson. (2013) Practice Tips and Tools for the Successful Use of U-500 Regular Human Insulin. The Diabetes Educator 40:2, pages 153-165.
Crossref
Crossref